World first: child-friendly tuberculosis treatment will be available from 2016

Health-e News

More than 30,000 children develop tuberculosis (TB) each year in South Africa. For these children, cure comes in the form of six months of daily, bitter pills made for adults more than twice their size.

Today, TB research non-profit the TB Alliance has announced a better cure in on the way for kids as the organisation launches new combination TB treatment for kids.

Monique Davids’ husband, three-year-old daughter and two-month-old son developed TB simultaneously.

After Jaden was hospitalised at Red Cross War Memorial Children's Hospital, Davids spent her days shuttling between the hospital and home – trying to get two very sick but very resistant young children to take their treatment.

For Davids, it meant taking up to seven adult-sized tablets and crushing them into powder she mixed with everything from formula to juice in an effort to get her children to take the life-saving treatment.

When her oldest child refused to take the treatment, she tired bribes before resorting to fear.

“I told her that if she didn’t take the treatment, the police would come from her,” Davids said. “It was very traumatic for me because I’d never lied to her before.”

According to Davids, many parents in her community give up the hard fight to get medicine down kids’ throat with deadly results.

Read: Khayelitsha clinic leads the way with new TB drug

Parents’ fights may get a little easier

On the 2nd of December, the TB Alliance has announced the creation of the world’s first combination TB treatments made especially for children and that adhere to international guidelines.

Funded by the medicine and diagnostic funder UNITAID, one new formulation combines the most commonly used TB drugs, rifampicin and isoniazid. A second new combination drug pairs the two staple TB drugs with a third TB drug, pyrazinamide.

At just about R220 per six-month course, the new formulations are dissolvable in water and come in strawberry or raspberry flavours. They also ensure that children will receive the proper drug doses – something that is not guaranteed when parents are forced to crush adult tablets into kid-sized powder.

While combination paediatric TB therapy exists, the new formulations are the first to adhere to international World Health Organisation recommended doses.

According to TB Alliance President and CEO Mel Spigelman, the new paediatric TB formulations, were developed in less than three years and for less money that was originally envisioned.

Read: Doctor saves child with drug-resistance TB in India

South Africa to license the drugs soon

Speaking at the World Conference on Lung Health in Cape Town, he added that the alliance will register and license the combination drugs for use in South Africa soon.

“Now that we have the drugs, the real work starts and that is to make sure that these drugs are adopted and actually accessible for the patients and families who need them,” he said.

“That is not an insignificant task,” added Spigelman alluding to the lack of paediatric TB tests needed to diagnose childhood TB.

TB Alliance researchers are also currently working on a kid-friendly version of the TB drug isoniazid, which can also be used to prevent the development of active TB as well as a paediatric formulation of the drug bedaquiline.

The first new drug in about 50 years, bedaquiline had been rolled out to about 150 patients with extensively drug-resistant TB in South Africa as of June.

The country is set to spend about R130million to roll out bedaquiline to at least 9,000 patients over the next three years, according to Dr Norbert Ndjeka, head of the Department of Health’s division on HIV, TB and drug-resistant TB.

Read more:

What are the symptoms of TB?

How can TB be prevented?

Drug-resistant tuberculosis: health official's biggest fear

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Nkosazana Dlamini-Zuma has got it in the bag
7% - 618 votes
I foresee a second term for Cyril Ramaphosa
83% - 7414 votes
Don’t discount a Zweli Mkhize win
10% - 921 votes
Rand - Dollar
Rand - Pound
Rand - Euro
Rand - Aus dollar
Rand - Yen
Brent Crude
Top 40
All Share
Resource 10
Industrial 25
Financial 15
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.